Amanda Wilde wants postpartum psilocybin studied directly. The strongest counterevidence comes from mice.
A Harvard-trained researcher wants the first controlled human study of psilocybin in postpartum mothers, arguing that widespread unsupervised use has already outpaced the evidence. A 2025 mouse study is the most direct data yet that the postpartum body responds differently to the drug, and it settles the question for neither side.
Read the work →